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Abstract 
Introduction and objective: Outer membrane proteins (OMPs) of Brucella are considered 
as immunogenic structures which can be used to design and develop a subunit vaccine for 
human brucellosis. Brucella abortus S99 OMPs promote the synthesis of high levels of 
specific anti-Brucella IgG molecules in rabbits when administrated with lipopolysaccharide 
(LPS). The objective of this study is evaluation of the efficacy of B. abortus major OMPs 
with LPS in the induction of immune response against brucellosis.  
Materials and methods: OMPs were derived from B. abortus by sequential extraction of 
sonicated cells with ultracentrifugation and predigestion with lysozyme. Proteins could be 
separated by anion-exchange chromatography and gel-filtration. Based on SDS-PAGE 
profiles, porins have been dominantly purified among three different classes of B. abortus 
OMPs. Sera of immunized rabbits against B. abortus porins were analyzed by enzyme-
linked immunosorbent assay (ELISA). LPS of B. abortus and complete Freud's adjuvant 
(CFA) were also applied to elicit higher levels of anti-Brucella antibodies. 
Results: ELISA confirmed the potency of porins and porins combination with CFA and LPS 
to promote humoral specific response. Among the above-mentioned compounds, a 
combination of porins + LPS or porins + CFA has been the most potent immunogenic 
compound to induce higher titer of antibody against B. abortus S99 in the animal model.  
Conclusion: The application of a complex of Brucella LPS and porins as an effective 
method to elicit protective and long-lasting immunity against Brucella infection and would 
be studied to design and develop a subunit vaccine for human brucellosis. 
Keywords: Brucella abortus S99; Outer membrane proteins; Porins; Lipopolysaccharide 
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Introduction 
Brucellosis is one of the most common 
bacterial zoonoses caused by organisms 
belonging to genus Brucella, Gram-
negative, non-spore-forming, facultative 
intracellular bacteria [1-3]. The genus 
Brucella consists of seven species 
according to antigenic variation and 
primary host. Brucella melitensis (sheep 
and goats), B. suis (hogs), B. abortus 
(cattle), B. ovis (sheep), B. canis (dogs), B. 
neotomae (wood rats) and B. maris (marine 
mammals) [4,5].  
Brucella abortus induces spontaneous 
abortion in cattle and causes economic and 
industrial loss. Although brucellosis has 
been a health hazard for man and domestic 
animals in many countries, a licensed 
human Brucella vaccine has not been 
designed and produced yet [6,7]. Currently, 
antigenic determinants of Brucella cell wall 
are considered as potential candidates to 
develop a subunit vaccine and substantial 
numbers of antigenic components of 
Brucella have been characterized [8]. 
However, one of the antigens that promotes 
the major antibody response is the 
lipopolysaccharide (LPS) [9,10].  
Numerous cytoplasmic and periplasmic 
protein antigens contain outer and inner 
membrane, have also been characterized. 
Ribosomal proteins have been interested in    
vaccine studies as immunological 
components with both humoral and cellular 
responses against brucellosis. In current 
study, we focused on potency of major 
outer membrane protein (OMP) of B. 
abortus S99 as protective antigens. 
Lysozyme digestion is necessary to release 
of OMPs from peptidoglycan (PG). The 
apparent molecular mass of OMPS of 
Brucella are used in their classification as 
group 1 (94 or 88KDa), group 2 (36-38 
KDa, identified as porins) [11-15] and 
group three (31-34 and 25-27 KDa). 
Recently these proteins have been used in 
vaccine studies and intra-species 
classification.  
We previously synthesized a subunit 
brucellosis vaccine composed of B. abortus 
S99 LPS with Neisseria meningitidis 
serogroup B outer membrane vesicle 
(GBMOMV) as a noncovalent complex and 
then evaluated specific antibody response 
against the LPS of B. abortus S99. We 
reported that our purified GBMOMV may 
be applied as a safe and potent 
subcutaneous adjuvant to induce high titres 
of specific anti-B. abortus S99 IgG and may 
be used in candidate vaccines for human 
brucellosis [16]. In the present study, we 
designed a subunit brucellosis vaccine 
composed of B. abortus S99 porins and 
LPS as a noncovalent complex and then 
evaluated specific antibody response against 
B. abortus S99.  
 
Materials and methods 
Bacterial strain 
Brucella abortus S-99 (biovar 1) was 
obtained from the type bacteria collection of 
Pasteur Institute of Iran. The bacteria were 
routinely grown on Brucella agar medium 
(Merck, Germany) at 37±1°C for 72h. Then 
the bacteria propagated into a 60 liter 
industrial fermentor (Nova-paljas, contact-
flow BV, Netherlands) with 40 liters 
working volume at 37±1°C. After 72h of 
incubation, the bacteria were inactivated 
with 10% phenol and biomass of B. abortus 
S99 harvested by centrifugation [17].  
 
Extraction of OMPs of B. abortus S99  
Cells were suspended at 1g (wet weight) per 
20ml of 10mM tris-hydrochloride buffer 
(pH=7.5), and 1mg each of DNase and 
RNase (Sigma chemical co., St. louis, MO) 
was added per 100ml. Samples were chilled 
on ice and sonicated in a Bronson Sonifer 
450, using a continuous cycle (seven pluses 
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per 1min) with a microtip. The samples 
were centrifuged twice at 3000g for 15min 
at 4°C to remove unbroken cells. The 
supernatants were submitted to 
ultracentrifugation at 43500rpm for 90mins 
to pellet the crude membranes. Pellets were 
collected and resuspended in 50mM tris-Hcl 
(pH=7.6) with 2mM phenyl methane 
sulfonyl fluoride (PMSF) as a protease 
inhibitor [18].  
Detergent extraction of cytoplasmic 
membranes was performed by using sodium 
N-lauroyl sarcosinate. Resultant soluble 
material was dialyzed against tris buffer at 
4°C for 72h with repeated changes. 
Lysozyme (1mg/50mg of membrane 
protein) was added to isolate the PG from 
OMPs. This process was followed by 
ultracentrifugation at 100,000g for 20mins 
at 4°C. The supernatants were held at 4°C 
[19]. 
 
Anion-exchange chromatography 
Solubilized membrane fractions were 
concentrated by lyophilization to 10 to 20 
mg/ml, equilibrated with 10mM tris buffer 
containing 0.1% zwittergent and 0.25M 
NaCl and applied to a column of DEAE-
sephacel (Pharmacia Fine chemicals, Inc., 
pis-cataway, NJ) equilibrated with the same 
buffer. Elution was performed at room 
tempreture with upward flow at a rate of 
2ml.cm-2.h-1. After the initial wash, a 
gradient of NaCl (0.25 to 0.75) was 
established and collected over a period of 
24h. Protein samples from the ion exchange 
column, concentrated by lyophilization, 
were separated under the same conditions of 
flow on a column of sephacryl S-300 
(Pharmacia Fine chemicals, Inc.) 
equilibrated with 10 mM tris buffer 
containing 0.1% zwittergent and 0.25M 
NaCl [20]. 
 
Protein content measurement 
Protein concentration was determined using 
the Nanodrop ND-1000 (full-spectrum, 
220-750nm) spectrophotometer which 
measures 1μl samples with high accuracy. 
The A280 method is applicable for purified 
proteins exhibiting absorbance at 280nm. 
This module displays the UV spectrum, 
measures the protein’s absorbance at 280 
nm (A280) and calculates the concentration 
(mg/ml). It automatically switches to the 0.2 
nm at very high concentrations of protein. 
In brief, 1μl sample added on the end of a 
fiber optic cable and the protein 
concentaration was calculated.  
 
SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) 
SDS-PAGE was performed on 12% 
polyacrylamide gel [21]. Prestained protein 
(Ferments Co. Finland) was used as marker. 
20μl of extract was loaded per wells. Power 
supply was regulated in 150V for 1h. After 
electrophoresis, the gel was stained with 
coomassie blue.  
 
Extraction of B. abortus S99 
lipopolysaccharide 
S-LPS extracted by hot phenol-water 
method [17,22]. In brief, 50g wet weight of 
cells was suspended in 170ml of distilled 
water followed by the addition of 190ml of 
90% (v/v) hot phenol (66°C). After 30mins, 
the mixture was centrifuged and phenol 
layer was removed. The LPS in the resultant 
mixture precipitated by cold methanol (4°C) 
and dissolved in 0.1M tris buffer. Proteinase 
K (50μg per 10mg protein) and then both 
DNase and RNase (50μg per 1mg nucleic 
acid) added to extracted samples to reduce 
protein and nucleic acid contaminations.  
 
Animal groups 
Three groups of 4-month-old, 2.5 to 3kg 
white rabbits have been immunized with 
different compounds as will be described in 
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the immunization procedure. Each group 
was consisted of three rabbits.  
 
Immunization procedure  
Animal models immunized intramuscularly 
with three different compounds: 1) porins of 
B. abortus S99: 120μg/ml of purified 
porins. 2) A combination of 120μg/ml of 
porins and 120μg/ml of LPS. 3) A 
combination of 120μg/ml of porins and the 
same volume of CFA [23]. Immunization 
carried out in 0, 7 and 14 days and immune 
sera collected in 0 (before the first injection 
and as the negative control), 7 (before the 
2nd injection), 14 (before the 3rd injection) 
and 21 (one week after the 3rd injection) 
days and pooled at -20°C [23,24].  
 
ELISA 
Anti-B. abortus S99 IgG titer of immunized 
animals demonstrated by ELISA method. 
Microtiter plates were coated with B. 
abortus S99 antigen (100μl per well) and 
incubated for 1h at 37°C. Wells were 
saturated for 1h at 37°C in blocking buffer 
(phosphate-buffered saline containing 0.1% 
casein per ml). Antisera were diluted 1000, 
10000 and 100000-fold and 100μl of each 
dilution added to each well and incubated 
for 1h.  
Wells were washed three times with 
phosphate buffer saline-azide (PBS-azide). 
Anti-rabbit IgG-HRP conjugated was added 
(100μl per well) and incubated for 30mins 
and wells were washed again. Afterwards, 
the substrate of 3,3,5,5-
tetramethylbenzidine (TMB) was added to 
the wells. Finally stop solution (50µl) was 
added to the wells and absorbance measured 
at 405nm using an automated ELISA plate 
reader (TECAN, Sunrise model, 
Switziland). The antibody titres expressed 
in OD units [19,20,25-27]. 
 
Statistical methods 
Antibody titres of groups of rabbits were 
expressed as means ± standard deviations. 
The significance of differences in ELISA 
titers at different time points was 
determined by Student’s T test. 
 
Results  
Extracted OMPs 
OMPs concentration has been reported to be 
6.27mg/ml by the Nanodrop ND-1000 (full-
spectrum, 220-750nm) spectrophotometer 
(Fig. 1). SDS-PAGE analysis indicated a 
band (36-38KDa) which would be classified 
as Brucella porins (Fig. 2). 
 
 
Fig. 1: Electrophoretic pattern of the extracted 
OMPs of B. abortus S99 (Left line) in 
comparison with protein marker (Righ line) 
Seyed Davar Siadat, et al.                                33  
 
Jundishapur Journal of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, 
Iran, Tel: +98611 3330074; Fax: +98611 3332036; URL: http://jjm.ajums.ac.ir; E-mail: editorial office: jjm@ajums.ac.ir 
JJM. (2011); 4(1): 29-36.  
 
 
Fig. 2: The plot measured purified protein concentration at 280nm by ND-1000 spectrophotometer  
 
LPS characterization 
The LPS content of the extracted sample 
(measured by the chromogenic LAL assay) 
was 108 endotoxin units (EU)/ml. The 
KDO content came out to be 1.3%. Also the 
protein content of the sample (measured by 
Lowry method) was <2.0 and the nucleic 
acid content was <1%. 
 
Specific antibody response against porins 
and LPS 
IgG antibody titers were assayed and 
expressed in OD unit ± SD (Table 1). The 
IgG titers in all of the samples have been 
significantly higher than negative control 
(P<0.05). The combination of Porins+LPS 
of B. abortus S99 promoted the highest 
humoral response to B. abortus S99 assayed 
one week after the 3rd injection (Table 1). In 
addition, in rabbit immunized with the 
combination of porins+LPS and porins + 
CFA, the antibody titers were significantly 
higher than that obtained from porins. 
Although the differences between the IgG 
tiers of these two groups (porins+LPS and 
porins+CFA) has not been significant 
(P>0.05), both of these groups significantly 
increased the IgG titer in comparison to the 
animals immunized with porins without 
LPS or CFA (P<0.05).  
 
Table 1: Anti-Brucella total IgG titers following immunization with three different compounds 
(Titers are expressed in OD unit) 
 
LPS: Lipopolysaccharide, CFA: Complete Freund’s adjuvant. 
 
Injected compounds Anti B. abortus S99 
IgG titer, one week 
after the 1st injection 
Anti B. abortus S99 
IgG titer, one week 
after the 2nd injection 
Anti B. abortus S99 
IgG titer, one week 
after the 3rd injection 
B. abortus S99 Porins 68242 ± 606 76326 ± 923 124270 ± 2660 
B. abortus S99 porins + 
CFA 
122681 ± 3026 132896 ±1693 136706   ± 1300 
B. abortus S99 Porins + B. 
abortus S99 LPS 
123989 ±2026 134726 ±2980 155847 ± 2220 
Negative Control <3 <3 <3 
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Discussion 
As previously indicated, the applied OMP 
extraction method in the present study led 
to the purification of B. abortus S99 porins 
and would be recommended as a specific 
method to extract and isolate this group of 
OMPs. Furthermore, the yield of this 
extraction method has been satisfactory 
since the concentration of the extracted 
porins is considerable. 
Anti-B. abortus S99 porins IgG titer 
exponentially and significantly increased in 
all of the groups as compared to the control 
group. The high levels of anti- B. abortus 
S99 IgG in comparison with the control 
group indicates the immunogenicity of B. 
abortus S99 porins and the accuracy of our 
Porin extraction procedure which does not 
interfere with the natural and immunogenic 
structure of Porins. Since porins + LPS and 
porins + CFA equally elicited the IgG titers, 
LPS of B. abortus S99 would be applied as 
a potent adjuvant (with the same effect of 
CFA) for porins of B. abortus S99.  
As previously described [28] LPS of B. 
abortus S99 is 10,000 fold less pyrogenic 
than E. coli LPS and it would be a 
promising aspect of the application of B. 
abortus S99 LPS as a new adjuvant with 
microbial origin while the high 
pyrogenicity, the local and systemic 
hypersensitivity reactions of enterobacterial 
LPS and Freund's adjuvants has limited 
their application for human antigens and 
vaccines. Although the epitopes of O-
polysaccharide (OPS) of LPS are strongly 
dominant over those of associated with 
outer membrane proteins and the majority 
of produced antibodies are specific for OPS, 
porins stimulate T-cell responses while LPS 
is a T-independent antigen and unable to 
promote immunological memory and 
memory T and B-Cells expansion [29].  
Since porins are less accessible to 
antibodies because of the long OPS chains 
in the smooth strains of Brucella (most of 
the wild type Brucella strains) and LPS 
lacks the immunological characteristics of 
T-dependent antigens, a combination of 
these two structures of B. abortus S99 may 
efficiently induce both humoral and cellular 
mechanisms. Low pyrogenicity of LPS in 
parallel with its high potency to induce 
specific anti-Brucella antibodies and 
possible application of this cell wall 
component as an adjuvant for Brucella 
porins that induce T-cells responses are all 
the factors that highly recommend the 
application of a complex of Brucella LPS 
and porins as an effective method to elicit 
protective and long-lasting immunity 
against Brucella infection and would be 
studied to design and develop a subunit 
vaccine for human brucellosis [30,31].  
Although there are a lot of proved 
efficient optimizations in the cultivation and 
fermentation conditions and also in the 
procedure of porins and LPS extraction 
[17,32], the main novelty of this study is the 
simultaneous application of one classic 
adjuvants along with LPS (as a candidate 
adjuvant) and the evaluation of these two 
adjuvants' potency to induce anti-B. abortus 
S99 LPS IgG antibodies. Bhattacharjee et 
al. [32] and Bhattacharjee et al. [33] have 
evaluated the outer membrane vesicle of 
Neisseria meningitidis serogroup B -B. 
melitensis strain 16M LPS non-covalent 
complex to elicit the immunity against 
brucellosis in mice, they have extracted the 
LPS from B. melitensis and applied outer 
membrane proteins of N. meningitidis as an 
adjuvant.  
 
Conclusion 
In the present study, we evaluated the 
efficacy of B. abortus Porins+LPS (LPS as 
a probable adjuvant) after intramuscular 
injections with two boosters (versus one 
booster) administrated two weeks (versus 
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one week) after the previous 
immunizations. After both boosters, the 
induced anti-B. abortus S99 IgG titres 
increased significantly. Also we reached 
higher titres of IgG in comparison with 
previous studies. According to the results of 
this study, a combination of porins and LPS 
of B. abortus S99 are recommended as 
potential candidates to design a subunit 
vaccine.  
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